COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1484: Articles 14831-14840  | Next

Escherichia coli recombinant expression of SARS-CoV-2 protein fragments.
McGuire, B. E., Mela, J. E., Thompson, V. C., Cucsksey, L. R., Stevens, C. E., McWhinnie, R. L., Winkler, D. F., Pelech, S., Nano, F. E.
10.1101/2021.06.22.449540 — Posted: 2021-06-23
SARS-CoV-2 neutralising antibodies in Dogs and Cats in the United Kingdom
Smith, S., Anderson, E., Cansado Utrilla, C., Prince, T., Farrell, S., Brant, B., Smyth, S., Noble, P.-J., Pinchbeck, G., Marshall, N., Roberts, L., Hughes, G., Radford, A., Patterson, E. I.
10.1101/2021.06.23.449594 — Posted: 2021-06-23
Molecular Genetic Analysis of SARS-CoV-2 Lineages in Armenia
Avetyan, D., Hakobyan, S., Nikoghosyan, M., Khachatryan, G., Sirunyan, T., Muradyan, N., Zakharyan, R., Chavushyan, A., Ghazaryan, H., Melkonyan, A., Stepanyan, A., Hayrapetyan, V., Atshemyan, S., Martirosyan, G., Melik-Andreasyan, G., Sargsyan, S., Ghazazyan, A., Aleksanyan, N., Nersisyan, L., Arakelyan, A.
10.1101/2021.06.19.21259172 — Posted: 2021-06-23
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka
Jeewandara, C., Guruge, D., Aberathna, I. S., Danasekara, S., Gunasekara, B., Pushpakumara, P. D., Madushanka, D., Jayathilaka, D., Ranasinghe, T., Somathilaka, G., Tanussiya, S., Jayadas, T., Kuruppu, H., Thashmi, N., Harvie, M., Wijayamuni, R., Schimanski, L., Tan, T., Rijal, P., Xiao, J., Ogg, G., Townsend, A., Malavige, G. N.
10.1101/2021.06.18.21259143 — Posted: 2021-06-23
PREVALENCE AND INCIDENCE OF ANTIBODIES AGAINST SARS-COV-2 AMONG PRIMARY HEALTHCARE PROVIDERS IN BELGIUM DURING ONE YEAR OF THE COVID-19 EPIDEMIC: PROSPECTIVE COHORT STUDY PROTOCOL
Adriaenssens, N., Scholtes, B., Bruyndonckx, R., Verbakel, J. Y., De Sutter, A., Heytens, S., Van den Bruel, A., Desombere, I., Van Damme, P., Goossens, H., Buret, L., Duysburgh, E., Coenen, S.
10.1101/2021.06.18.21259139 — Posted: 2021-06-23
Two-Month Follow-up of Persons with SARS-CoV-2 Infection: Zambia, September 2020
Zulu, J. E., Banda, D., Hines, J. Z., Luchembe, M., Sivile, S., Siwingwa, M., Kampamba, D., Zyambo, K. D., Chirwa, R., Chirwa, L., Malambo, W., Barradas, D. T., Sinyange, N., Agolory, S., Mulenga, L., Fwoloshi, S.
10.1101/2021.06.15.21258964 — Posted: 2021-06-23
Predicting COVID-19 incidence in French hospitals using human contact network analytics
Selinger, C., Choisy, M., Alizon, S.
10.1101/2021.06.17.21258666 — Posted: 2021-06-23
SARS-CoV-2 under an elimination strategy in Hong Kong
Gu, H., Xie, R., Adam, D. C., Tsui, J. L.- H., Chu, D. K., Chang, L. D. J., Cheuk, S. S. Y., Gurung, S., Krishnan, P., Ng, D. Y. M., Liu, G. Y. Z., Wan, C. K. C., Edwards, K. M., Leung, K. S. M., Wu, J. T., Tsang, D. N. C., Leung, G. M., Cowling, B. J., Peiris, M., Lam, T. T. Y., Dhanasekaran, V., Poon, L.
10.1101/2021.06.19.21259169 — Posted: 2021-06-23
Small-molecule metabolome identifies potential therapeutic targets against COVID-19
Bennet, S. M. P., Kaufmann, M., Takami, K., Sjaarda, C., Douchant, K., Moslinger, E., Wong, H., Reed, D. E., Ellis, A. K., Vanner, S., Colautti, R. I., Sheth, P. M.
10.1101/2021.06.18.21259150 — Posted: 2021-06-23
Clinical profiles at the time of diagnosis of COVID-19 in Costa Rica during the pre-vaccination period using a machine learning approach
Molina-Mora, J. A., Gonzalez, A., Jimenez-Morgan, S., Cordero-Laurent, E., Brenes, H., Soto-Gatira, C., Sequeira-Soto, J., Duarte-Martinez, F.
10.1101/2021.06.18.21259157 — Posted: 2021-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).